Role of cardiac magnetic resonance imaging in identification of amyloid cardiomyopathy [1]

Indian Heart Journal

Volumn 56, Issue 6, 2004, Pages 682-683

  Crean, Andrew ^a   Merchant, Naeem ^a  

^a TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PYROPHOSPHATE TECHNETIUM TC 99M;

COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; HEART AMYLOIDOSIS; HYPERTROPHIC CARDIOMYOPATHY; LETTER; NUCLEAR MAGNETIC RESONANCE IMAGING; SCINTISCANNING;

AMYLOIDOSIS; CARDIOMYOPATHY, HYPERTROPHIC; DIAGNOSIS, DIFFERENTIAL; HUMANS; MAGNETIC RESONANCE IMAGING; RADIONUCLIDE IMAGING; TOMOGRAPHY, X-RAY COMPUTED;

EID: 14144251878     PISSN: 00194832     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (4)

1. Kothari SS, Ramakrishnan S, Bahl VK. Cardiac amyloidosis - an update. Indian Heart J 2004; 56: 197-203
2. Fattori R, Rocchi G, Celletti F, Bertaccini P, Rapezzi C, Gavelli G. Contribution of magnetic resonance imaging in the differential diagnosis of cardiac amyloidosis and symmetric hypertrophic cardiomyopathy. Am Heart J 1998; 136: 824-830
3. Celletti F, Fattori R, Napoli G, Leone O, Rocchi G, Reggiani LB, et al. Assessment of restrictive cardiomyopathy of amyloid or idiopathic etiology by magnetic resonance imaging. Am J Cardiol 1999; 83: 798-801
4. Karp K, Naslund U, Backman C, Eriksson P. Technetium-99m pyrophosphate single-photon emission computed tomography of the heart in familial amyloid polyneuropathy. Int J Cardiol 1987; 14: 365-369